If you are seeing this message, there was a problem loading the default style. Please click one of the Text Sizes below, which will fix this issue.
News
November 14, 2007

Open enrollment for Medicare Part D
Full Story | News Archive | Topics: , , , ,

With six weeks of an open enrollment period to make changes in Medicare Part D coverage beginning Nov. 15, the Kaiser Family Foundation examined 1824 stand alone plans and estimates that premiums are likely to increase an average of 17 percent (for those staying in the same plan), with the top three plans averaging 27 percent.



Seniors, and those who advise them, might take note of the October issue of Psychiatric Services which says restrictions in some drug plans under Medicare Part D "may restrict psychotropic medications more than state Medicaid programs do. This may have important implications for patients dually eligible for Medicare and Medicaid whose medications previously were covered under Medicaid.”



This becomes a practical concern for seniors. In an AARP survey (N=800), depression ranks sixth (of 11 chronic illnesses) with 15 percent of the respondents, in people over 50.

   Post a Comment

MIWatch would love to hear your thoughts. Please join the discussion.


characters left

Text Size default medium big large
Consider This

Who gets the (Medicare) advantage?
by Phyllis Vine

Mental health reform needs input
by Phyllis Vine

Goodwin under the bus
by Phyllis Vine

Local ballot boxes '08
by Phyllis Vine

PARITY PASSES -- Kudos
by Phyllis Vine

Full Consider This Archives

Subscribe via Email
Browse by Topic
MIWatch Archives
Recent Columns

Commentary
Coming off medications: A harm reduction approach
by Will Hall

Commentary
Overcrowded psychiatric emergency rooms
by Anthony T. Ng

Interviews
Q & A with Ron Manderscheid: agenda for reform
by Phyllis Vine

Commentary
Helping college students: PADs on campus
by Anna Scheyett

Commentary
Graduate school and mental illness...intertwined needs and success
by KR.Avilés-Vázquez

Commentary
Economic Security: Key to Recovery and Self-Determination
by Judith A. Cook

Commentary
A proposal for transitional crisis beds
by Sol Wachtler

Commentary
Psychiatric Advance Directives: A tool for patients and clinicians
by Marvin Swartz

Commentary
Access to care: training consumers and case managers
by Jack Carney

Commentary
Race, genetics, metabolism: drug therapy and clinical trials
by L. DiAnne Bradford

Full Columnist Listing

Reviews

Reform medicine, say authors
by Phyllis Vine

"Another Kind of VALOR"
by Phyllis Vine

"A Fight To Be," Ronald Bassman, Ph.D.
by Paul Pines

"Comfortably Numb: How Psychiatry is Medicating a Nation," Charles Barber
by Alison Bateman-House

"The Insanity Offense," E. Fuller Torrey
by Sue E. Estroff, Ph.D.